| Product Code: ETC7643047 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Ireland continues to be a key destination for viral vectors and plasmid DNA imports, with the USA, UK, Germany, Metropolitan France, and Serbia leading the way in 2024. Despite a high concentration level indicated by the Herfindahl-Hirschman Index (HHI), the market experienced a negative compound annual growth rate (CAGR) of -4.18% from 2020 to 2024. The growth rate in 2024 experienced a significant decline of -30.16%, reflecting potential shifts or challenges in the market dynamics. Monitoring these trends will be crucial for stakeholders in the industry to understand and adapt to changing market conditions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Viral Vectors and Plasmid DNA Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Viral Vectors and Plasmid DNA Market - Industry Life Cycle |
3.4 Ireland Viral Vectors and Plasmid DNA Market - Porter's Five Forces |
3.5 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Ireland Viral Vectors and Plasmid DNA Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growth in demand for gene therapy and genetic engineering applications |
4.2.2 Increasing investments in biotechnology and pharmaceutical research |
4.2.3 Technological advancements in viral vectors and plasmid DNA production |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for gene therapy products |
4.3.2 High production costs associated with viral vectors and plasmid DNA |
4.3.3 Limited availability of skilled professionals in the field |
5 Ireland Viral Vectors and Plasmid DNA Market Trends |
6 Ireland Viral Vectors and Plasmid DNA Market, By Types |
6.1 Ireland Viral Vectors and Plasmid DNA Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Plasmid DNA, 2022 - 2032F |
6.1.4 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Vectors, 2022 - 2032F |
6.1.5 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Non-viral Vectors, 2022 - 2032F |
6.2 Ireland Viral Vectors and Plasmid DNA Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Cancers, 2022 - 2032F |
6.2.3 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Inherited Disorders, 2022 - 2032F |
6.2.4 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Viral Infections, 2022 - 2032F |
6.2.5 Ireland Viral Vectors and Plasmid DNA Market Revenues & Volume, By Others, 2022 - 2032F |
7 Ireland Viral Vectors and Plasmid DNA Market Import-Export Trade Statistics |
7.1 Ireland Viral Vectors and Plasmid DNA Market Export to Major Countries |
7.2 Ireland Viral Vectors and Plasmid DNA Market Imports from Major Countries |
8 Ireland Viral Vectors and Plasmid DNA Market Key Performance Indicators |
8.1 Research and development expenditure in gene therapy and genetic engineering |
8.2 Number of clinical trials utilizing viral vectors and plasmid DNA in Ireland |
8.3 Adoption rate of gene therapy products in the Irish healthcare system |
9 Ireland Viral Vectors and Plasmid DNA Market - Opportunity Assessment |
9.1 Ireland Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Ireland Viral Vectors and Plasmid DNA Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Ireland Viral Vectors and Plasmid DNA Market - Competitive Landscape |
10.1 Ireland Viral Vectors and Plasmid DNA Market Revenue Share, By Companies, 2025 |
10.2 Ireland Viral Vectors and Plasmid DNA Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here